micro-community-banner
 
Profile Image
  • Saved
Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review

Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review

Source : https://pubmed.ncbi.nlm.nih.gov/36651193/

The findings of this systematic review support the use of serum AMH to study the age of menopause in population studies. The increased sensitivity of current AMH assays provides improved...

The findings of this systematic review support the use of serum AMH to study the age of menopause in population studies. The increased sensitivity of current AMH assays provides improved accuracy for the prediction of imminent menopause, but diagnostic use for individual patients has not been rigorously examined.

Profile Image
  • Saved
Cognitive Decline in Early and Premature Menopause

Cognitive Decline in Early and Premature Menopause

Source : https://pubmed.ncbi.nlm.nih.gov/37047549/

Early and premature menopause, or premature ovarian insufficiency (POI), affects 1% of women under the age of 40 years. This paper reviews the main aspects of early and premature menopause...

Early menopause increases cognitive decline risk; menopausal hormone therapy may reduce mild cognitive impairment and Alzheimer's risk. Multidisciplinary care is crucial for mental health in affected women.

Profile Image
  • Saved
Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT

Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT

Source : https://pubmed.ncbi.nlm.nih.gov/36734148/

Daily fezolinetant 30 and 45 mg were efficacious and well tolerated for treating moderate to severe VMS associated with menopause.

Daily fezolinetant 30 and 45 mg were efficacious and well tolerated for treating moderate to severe VMS associated with menopause.

Profile Image
  • Saved
The Importance of Nutrition in Menopause and Perimenopause-A Review

The Importance of Nutrition in Menopause and Perimenopause-A Review

Source : https://pubmed.ncbi.nlm.nih.gov/38201856/

Menopause is associated with an increased prevalence of obesity, metabolic syndrome, cardiovascular diseases, and osteoporosis. These diseases and unfavorable laboratory values, which are characteristic of this period in women, can...

In summary, during the period of perimenopause and menopause, many lifestyle factors can reduce the risk of developing all the diseases (cardiovascular disease, insulin resistance, type 2 diabetes mellitus, osteoporosis, and tumors) and symptoms characteristic of this period.

Profile Image
  • Saved
Probiotics and Prebiotics: Any Role in Menopause-Related Diseases

Probiotics and Prebiotics: Any Role in Menopause-Related Diseases

Source : https://pubmed.ncbi.nlm.nih.gov/36746877/

The human microbiota is a complex community that lives in a mutualism relationship with the host. Menopause is associated with dysbiosis, and these changes in the composition of microbiota in...

Microbiota changes during menopause may influence various diseases, and while probiotics show potential benefits, further research is needed to confirm their therapeutic efficacy.

Profile Image